The battle in the courts among providers, drug manufacturers, and health officials over 340B contract pharmacy likely will take time to play out, 340B Report Publisher and CEO Ted Slafsky writes in his latest column for Omnicell (a 340B Report sponsor).
“It could be at least a few months before we see concrete action” in manufacturers’ and provider groups’ contract pharmacy-related suits against the U.S. Health and Human Services Department (HHS), and in contract pharmacy-related proceedings providers initiated under the new 340B program administrative dispute resolution (ADR) system, Slafsky said. Community health centers and HIV/AIDS clinics have paused their contract pharmacy lawsuits against HHS to let the ADR process play out.
